American Science and Engineering, Inc. Reports Results for

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
American Science and Engineering, Inc. Reports Results for Third Quarter Fiscal Year 2014
  • Company Declaring Quarterly Dividend of $0.50 per share
  • New Customers Accounted for 36% of Bookings in Q3
  • 38 ZBVs booked in the Quarter — 700 booked to-date

BILLERICA, Mass., Feb. 4, 2014 (GLOBE NEWSWIRE) -- American Science and Engineering, Inc. (Nasdaq: ASEI ) ("AS&E"), a leading worldwide supplier of innovative X-ray detection solutions, today reports its financial results for the third quarter of fiscal year 2014 ended December 31, 2013. The Company is reporting revenues of $37.8 million as compared with revenues of $50.8 million for the third quarter of fiscal year 2013, net income of $1.6 million as compared with net income of $6.1 million for the third quarter of fiscal year 2013, and earnings per share of $0.20 as compared with earnings per share of $0.73 for the third quarter of fiscal year 2013.

For the first nine months of fiscal year 2014 ended December 31, 2013, the Company is reporting revenues of $124.7 million compared with revenues of $144.4 million for the same period in the prior fiscal year, net income of $11.2 million compared with net income of $16.7 million for the same period in the prior fiscal year, and earnings per share of $1.41 compared with earnings per share of $1.95 for the prior fiscal year.

The Company is reporting $43.7 million in bookings for the third quarter of fiscal year 2014 and $119.4 million for the first nine months of fiscal year 2014. Backlog at December 31, 2013 was $180.9 million.

Continuing with its dividend program started in August 2007, the Company is declaring a quarterly cash dividend of $0.50 per share, payable on March 3, 2014 to the holders of record at the close of business on February 18, 2014.

"Quarterly results for revenue and EPS were negatively impacted by a sizable shipment that was delayed while in transit to the customer," said Chuck Dougherty, AS&E's President and Chief Executive Officer. "Absent this delay, revenues would have been consistent with previous quarters, as we continue to make excellent progress on our key growth initiatives. New customers accounted for 36% of our third quarter bookings with new clients added in the Middle East, the European Union, North America, and the Commonwealth of Independent States (CIS). Additionally, we continue to successfully execute on our solid ZBV pipeline in key geographic markets, with six new ZBV customers added and 38 ZBV systems booked in the quarter, including the largest single international ZBV booking in the Company's history."

Chuck Dougherty, President and Chief Executive Officer, and Ken Galaznik, Senior Vice President, Chief Financial Officer and Treasurer, will host a conference call and simultaneous audio webcast on Wednesday, February 5, 2014 at 8:30 a.m. ET to discuss the results and respond to questions. To participate in the conference call, please dial 1-877-303-9143 at least 10 minutes prior to its starting time. For international participants, please dial 1-760-536-5194 . The conference identification number is 35133713 . You will be placed on hold until the conference call is ready to begin. The live audio webcast can be accessed through the investor relations section of the Company's website at http://ir.as-e.com/events.cfm .

An audio replay of the teleconference will be available, in its entirety, starting Wednesday, February 5, 2014 at 11:30 a.m. ET for a one-week period by dialing 1-855-859-2056. Internationally, please dial 1-404-537-3406. The conference identification number is 35133713 . The replay will also be available through the Company's web site at http://ir.as-e.com/events.cfm .

About AS&E

American Science and Engineering, Inc. (AS&E) is the trusted global provider of threat and contraband detection solutions for ports, borders, military, critical infrastructure, law enforcement, and aviation. With over 50 years of experience, AS&E offers proven, advanced, X-ray inspection systems to combat terrorism, drug smuggling, illegal immigration and trade fraud. AS&E systems are designed in a variety of configurations for cargo and vehicle inspection , parcel inspection , and personnel screening . Using a combination of technologies, these systems provide superior detection capabilities, with high-energy, dual-energy, and Z Backscatter ™ X-rays — pioneered by AS&E. Learn more about AS&E products and technologies at www.as-e.com .

Safe Harbor Statement : The foregoing press release contains statements concerning AS&E's financial performance, markets and business operations that may be considered "forward-looking" under applicable securities laws. AS&E wishes to caution readers of this press release that actual results might differ materially from those projected in any forward-looking statements. Factors which might cause actual results to differ materially from those projected in the forward-looking statements contained herein include the following: significant reductions, delays or cancellations (in full or in part) in procurements of the Company's systems by the United States and other governments; disruption in the supply of any source component incorporated into AS&E's products; litigation seeking to restrict the use of intellectual property used by the Company; limitations under certain laws on the Company's ability to protect its own intellectual property; potential product liability claims against the Company; global political trends and events which affect public perception of the threat presented by drugs, explosives and other contraband; global economic developments and the ability of governments and private organizations to fund purchases of the Company's products to address such threats; the potential insufficiency of Company resources, including human resources, capital, plant and equipment and management systems, to accommodate any future growth; technical problems and other delays that could impact new product development and the Company's ability to adapt to changes in technology and customer requirements; competitive pressures; lengthy sales cycles both in United States government procurement and procurement abroad; future delays in federal funding, the market price of the company's stock prevailing from time to time, the nature of other investment opportunities presented to the company from time to time, the company's cash flows from operations and market and general economic conditions. These and certain other factors which might cause actual results to differ materially from those projected are detailed from time to time in AS&E's periodic reports and registration statements filed with the Securities and Exchange Commission, which important factors are incorporated herein by reference. AS&E undertakes no obligation to update forward looking statements to reflect changed assumptions, the occurrence of unanticipated events, or changes in future operating results, financial condition or business over time. Readers are further advised to review the "Risk Factors" set forth in the Company's most recent Form 10-Q and Form 10-K, which further detail and supplement the factors described in this Safe Harbor Statement. Among other disclosures, the Risk Factors disclose risks pertaining to that portion of the Company's business that is dependent on United States government contracting as well as international customers.

AMERICAN SCIENCE AND ENGINEERING, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share amounts)
(unaudited)
         
  Quarter Ended Nine Months Ended
  December 31,
2013
December 31,
2012
December 31,
2013
December 31,
2012
Total net sales and contract revenues $ 37,773 $ 50,803 $ 124,673 $ 144,400
         
Total cost of sales and contract revenues 20,905 28,103 69,452 79,230
Gross profit 16,868 22,700 55,221 65,170
         
Expenses:        
Selling, general and administrative expenses 8,396 8,280 22,718 21,173
Research and development costs 6,139 5,242 15,725 18,862
Total operating expenses 14,535 13,522 38,443 40,035
         
Operating income 2,333 9,178 16,778 25,135
Interest and other, net 11 54 8 159
Income before provision for income taxes 2,344 9,232 16,786 25,294
Provision for income taxes 786 3,139 5,624 8,600
         
Net income $ 1,558 $ 6,093 $ 11,162 $ 16,694
         
Income per share - Basic $ 0.20 $ 0.74 $ 1.42 $ 1.97
Income per share - Diluted $ 0.20 $ 0.73 $ 1.41 $ 1.95
         
Weighted average shares - Basic 7,850 8,247 7,837 8,488
Weighted average shares - Diluted 7,889 8,307 7,873 8,542
         
The results of operations reported herein may not be indicative of future financial conditions or results of future operations.
 
AMERICAN SCIENCE AND ENGINEERING, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands)
(unaudited)
     
  December 31, 2013 March 31, 2013
Assets    
Current assets:    
Cash and cash equivalents  $ 65,965  $ 40,418
Restricted cash and investments 14,753 12,618
Short-term investments, at fair value 86,428 108,546
Accounts receivable, net 22,591 28,477
Unbilled costs and fees 2,484 4,875
Inventories, net 50,144 48,051
Other current assets 9,101 11,984
Total current assets 251,466 254,969
     
Non-current assets:    
Building, equipment and leasehold improvements, net 13,972 16,451
Restricted cash and investments 397 899
Other assets 8,687 9,130
Total assets  $ 274,522  $ 281,449
     
Liabilities & Stockholders' Equity    
Current liabilities:    
Accounts payable  $ 8,913  $ 8,371
Customer deposits 33,131 16,199
Deferred revenue 11,410 15,770
Other current liabilities 19,884 28,148
Total current liabilities 73,338 68,488
     
Non-current liabilities:    
Lease financing liability 1,783 2,914
Other non-current liabilities 3,695 5,802
Total liabilities 78,816 77,204
     
Stockholders' equity 195,706 204,245
Total liabilities and stockholders' equity  $ 274,522  $ 281,449
 
AMERICAN SCIENCE AND ENGINEERING, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
(unaudited)
     
  For the Nine Months Ended
  December 31,
2013
December 31,
2012
Cash flows from operating activities:    
Net income  $ 11,162  $ 16,694
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 3,942 3,821
Provisions for contracts, inventory and accounts receivable reserves 1,233 3,503
Amortization of bond premium 1,192 2,151
Deferred income taxes  1,894  152
Other --  (59)
Stock compensation expense (credit) 1,527 (85)
     
Changes in assets and liabilities:    
Accounts receivable 5,952 (14,907)
Unbilled costs and fees 2,391 (859)
Inventories (3,392) 453
Prepaid expenses and other assets 1,432 684
Accounts payable 542 (892)
Accrued income taxes  (2,094)  879
Customer deposits 16,932 9,580
Deferred revenue (6,472) 81
Accrued expenses and other liabilities (6,181) (296)
Net cash provided by operating activities 30,060 20,900
     
Cash flows from investing activities:    
Purchases of short-term investments (47,805) (99,719)
Proceeds from sales and maturities of short-term investments 68,755 150,514
Purchases of property and equipment, net (1,463) (2,500)
Net cash provided by investing activities 19,487 48,295
     
Cash flows from financing activities:    
Increase in restricted cash and investments (1,633) (1,384)
Proceeds from exercise of stock options 2,889 1,079
Repurchase of shares of common stock  (12,306)  (45,347)
Repayment of leasehold financing liability (1,115) (1,003)
Payment of common stock dividend (11,749) (12,760)
Reduction of income taxes paid due to the tax benefit from employee stock option exercises  (86)  --
Net cash used for financing activities (24,000) (59,415)
     
Net increase in cash and cash equivalents 25,547 9,780
Cash and cash equivalents at beginning of period 40,418 24,369
Cash and cash equivalents at end of period  $ 65,965  $ 34,149

Investor Relations Contact: Annemarie Sadowski American Science and Engineering, Inc. 978-262-8828 Public Relations Contact: Dana Harris Red Javelin Communications, Inc. 978-440-8392 Laura Berman American Science and Engineering, Inc. 978-262-8713

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lilly's Retatrutide Outshines Ozempic in Key Diabetes Trial

Updated Category News Views 24

Lilly's Breakthrough in Diabetes Treatment Eli Lilly's retatrutide is stirring up the diabetes treatment waters. The latest Phase 3 comparison to Ozempic's top dose reveals some surprising results. I'm not one to toss out kudos lightly, but this could be a genuine game-changer if things hold steady. A1C Reductions: A Close Look at the Numbers We’re staring down the...

Continue Reading
Samuel Oschin Air & Space Center Takes Flight This Fall

Updated Category News Views 98

The Grand Unveiling: November Highlights Look at this: space nerds, dreamers, and just about anybody with a heartbeat and a sense of wonder should circle November 13, 2026, like a kid with a candy store gift card. That's when the California Science Center throws open the doors to the Samuel Oschin Air and Space Center. You might as well slap a 'world's first' sticker on...

Continue Reading
Unicycive Faces Legal Heat: Shareholder Lawsuit Looms

Updated Category News Views 104

The Unicycive Landslide: What Went Down? Investors, buckle up. Unicycive Therapeutics Inc. (NASDAQ: UNCY) finds itself deep in the muck of a securities class action. Chief honchos, CEO Shalabh Gupta and CFO John Townsend, are taking the heat for allegedly controlling company disclosures that led shareholders to believe in non-existent progress with their third-party...

Continue Reading
Navigating Gas-to-AI Power: Challenges & Opportunities

Updated Category News Views 83

Natural Gas Abundance Meets Conversion Hurdles It’s a wild scene when you've got oodles of natural gas but struggle to get it into AI data centers. That’s the picture today: U.S. gas production hitting a high of 137 billion cubic feet daily, while converting that gas into practical energy is the real challenge. You see, the gas market is ready to rumble, ticking...

Continue Reading
Ameritas Hires Actuarial Veteran as VP in Strategic Move

Updated Category News Views 115

Shifting Gears at Ameritas: New VP Takes the Helm Well, chalk one up for Ameritas on this move. They've just brought on Ying Zhao as the new vice president of actuarial and financial strategy. It's a mouthful of a title, sure, but it's the role itself that's worth watching. Ameritas, for those not tracking, is a major player in the insurance and financial universe, doing...

Continue Reading
Replay Sports Cards Nets STAR Award for Innovation

Updated Category News Views 82

A New Era for Franchise Onboarding Just when you think the sports card world couldn't get any more niche, along comes Replay Sports Cards thumping its chest with some serious innovation. This Charlotte-based franchise just snagged the Franchise Innovation Award from Franchise Update Media. Yep, they're the only ones getting tips of the hat for the Most Innovative...

Continue Reading
Step into Fear: Dead by Daylight in Moreno Valley

Updated Category News Views 54

Immersive Horror in Moreno Valley Walking straight into the fog of your nightmares isn't for the faint-hearted, but that's the kind of thrill the Moreno Valley Museum & ArtSpace is serving up with its new Dead by Daylight Immersive Experience. Kicking off just in time for Halloween on October 30, this isn't your average stroll in a museum—it's a heart-pounding,...

Continue Reading
Armani/Casa Miami Earns Forbes Designation for Luxury

Updated Category News Views 34

Where Luxury Meets Thoughtfulness Residences by Armani/Casa Miami just nabbed a VERIFIED™ Luxury Residences badge from the Forbes Travel Guide folks. Now, you might be wondering why this is significant or if it's just another shiny tag in a world already glistening with luxury concepts. Well, there's a shift happening here, and it's got some meat to it. The folks...

Continue Reading
South Dakota's BEES Launch: Child Care Assistance Goes Live

Updated Category News Views 24

RedMane and South Dakota DSS: A New Milestone Talk about a leap into the digital age. South Dakota's Department of Social Services, teaming up with RedMane Technology, has just rolled out the Child Care Assistance Program on their BEES platform. That’s Benefits Eligibility and Enrollment System for those not keeping track. It represents a significant step in making life...

Continue Reading
QFIN Faces Lawsuit Over Broken Promises and Revenue Plunge

Updated Category News Views 48

Unmasking the Hype: QFIN's Pledge and Performance Investors, gather 'round because QFIN's latest uproar ain't pretty. The folks over at Qfin Holdings have found themselves in hot water, facing a class action lawsuit for allegedly pulling the wool over investors' eyes. Between March and August 2026, they promised a rock-solid ship braving China’s regulatory storm. Turns...

Continue Reading

Top 5 Most Recently Viewed Articles

BCMGlobal Takes Charge of NFSC's Loan Servicing Evolution

Updated Category News Views 197

BCMGlobal's New Role in Advancing NFSC BCMGlobal has been appointed to strategically manage the National Financing Support Services Company (NFSC), elevating it to a leading independent loan servicer. This initiative aims to promote excellence in the sector. Supporting Saudi Arabia's Financial Vision The NFSC, established with the backing of the Saudi Real Estate...

Continue Reading
Breakthrough MRD Data from Myriad Genetics at Cancer Conference

Updated Category News Views 201

Innovative Insights into MRD Testing Myriad Genetics, Inc. (NASDAQ: MYGN), a prominent name in molecular diagnostics and precision medicine, is set to unveil exciting new clinical findings related to their Precise MRD test at a significant annual meeting dedicated to cancer research. Presentation Highlights During the conference, Dr. Chad Tang from The University of Texas...

Continue Reading
SBM Offshore's Recent Share Buyback Program: Key Insights

Updated Category News Views 119

SBM Offshore's Share Buyback Program Overview SBM Offshore has recently reported on its significant share repurchase program, valued at EUR130 million (approximately US$140 million), covering transactions made from November 21, 2024, to November 27, 2024. This initiative underscores the company’s commitment to enhancing shareholder value through systematic buybacks. Key...

Continue Reading
Investigation into Akero Therapeutics by Berger Montague PC

Updated Category News Views 165

Akero Therapeutics Under Investigation by Berger Montague Berger Montague PC, a respected law firm, recently brought to attention an ongoing investigation into the practices of Akero Therapeutics, Inc. The investigation focuses on potential breaches of fiduciary duties and violations of federal securities laws by Akero’s Board of Directors, which has crucial...

Continue Reading
Nkarta's Upcoming Interactive Session: What to Expect?

Updated Category News Views 127

Nkarta to Engage with Investors in H.C. Wainwright Series Nkarta, Inc. (NASDAQ: NKTX), a pioneering clinical-stage biopharmaceutical firm dedicated to creating innovative engineered natural killer (NK) cell therapies, recently announced its notable role in the H.C. Wainwright "HCW@Home" Series. This virtual series will allow investors and interested parties to gain deeper...

Continue Reading